The combined effect and mechanism of antiangiogenic drugs and PD-L1 inhibitor on cell apoptosis in triple negative breast cancer

Jing Li; Dianbao Zhang; Zhiwei Liu; Yukun Wang; Xinyang Li; Ziming Wang; Gaofeng Liang; Xiang Yuan; Yuanpei Li; Andrzej L Komorowski; Warren Matthew Rozen; Armando Orlandi; Kazuaki Takabe; Gianluca Franceschini; Guy Jerusalem; Xinshuai Wang

doi:10.21037/atm-22-6446

The combined effect and mechanism of antiangiogenic drugs and PD-L1 inhibitor on cell apoptosis in triple negative breast cancer

Jing Li
, Dianbao Zhang
, Zhiwei Liu
, Yukun Wang
, Xinyang Li
, Ziming Wang
, Gaofeng Liang
, Xiang Yuan
, Yuanpei Li
, Andrzej L Komorowski
, Warren Matthew Rozen
, Armando Orlandi
, Kazuaki Takabe
, Gianluca Franceschini
, Guy Jerusalem
, Xinshuai Wang

Risultato della ricerca: Contributo in rivista › Articolo

Lingua originale	Inglese
pagine (da-a)	83-83
Numero di pagine	1
Rivista	Annals of Translational Medicine
Volume	11
DOI	https://doi.org/10.21037/atm-22-6446
Stato di pubblicazione	Pubblicato - 2023

Keywords

PD-L1 inhibitor
Triple-negative breast cancer (TNBC)
anlotinib
apoptosis
treatment

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.21037/atm-22-6446

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Li, J., Zhang, D., Liu, Z., Wang, Y., Li, X., Wang, Z., Liang, G., Yuan, X., Li, Y., Komorowski, A. L., Rozen, W. M., Orlandi, A., Takabe, K., Franceschini, G., Jerusalem, G., & Wang, X. (2023). The combined effect and mechanism of antiangiogenic drugs and PD-L1 inhibitor on cell apoptosis in triple negative breast cancer. Annals of Translational Medicine, 11, 83-83. https://doi.org/10.21037/atm-22-6446

@article{ffc966cbe23842e58b32ea571ba783e1,

title = "The combined effect and mechanism of antiangiogenic drugs and PD-L1 inhibitor on cell apoptosis in triple negative breast cancer",

keywords = "PD-L1 inhibitor, Triple-negative breast cancer (TNBC), anlotinib, apoptosis, treatment, PD-L1 inhibitor, Triple-negative breast cancer (TNBC), anlotinib, apoptosis, treatment",

author = "Jing Li and Dianbao Zhang and Zhiwei Liu and Yukun Wang and Xinyang Li and Ziming Wang and Gaofeng Liang and Xiang Yuan and Yuanpei Li and Komorowski, \{Andrzej L\} and Rozen, \{Warren Matthew\} and Armando Orlandi and Kazuaki Takabe and Gianluca Franceschini and Guy Jerusalem and Xinshuai Wang",

year = "2023",

doi = "10.21037/atm-22-6446",

language = "English",

volume = "11",

pages = "83--83",

journal = "Annals of Translational Medicine",

issn = "2305-5839",

publisher = "AME Publishing Company",

}

Li, J, Zhang, D, Liu, Z, Wang, Y, Li, X, Wang, Z, Liang, G, Yuan, X, Li, Y, Komorowski, AL, Rozen, WM, Orlandi, A, Takabe, K, Franceschini, G, Jerusalem, G & Wang, X 2023, 'The combined effect and mechanism of antiangiogenic drugs and PD-L1 inhibitor on cell apoptosis in triple negative breast cancer', Annals of Translational Medicine, vol. 11, pagg. 83-83. https://doi.org/10.21037/atm-22-6446

TY - JOUR

T1 - The combined effect and mechanism of antiangiogenic drugs and PD-L1 inhibitor on cell apoptosis in triple negative breast cancer

AU - Li, Jing

AU - Zhang, Dianbao

AU - Liu, Zhiwei

AU - Wang, Yukun

AU - Li, Xinyang

AU - Wang, Ziming

AU - Liang, Gaofeng

AU - Yuan, Xiang

AU - Li, Yuanpei

AU - Komorowski, Andrzej L

AU - Rozen, Warren Matthew

AU - Orlandi, Armando

AU - Takabe, Kazuaki

AU - Franceschini, Gianluca

AU - Jerusalem, Guy

AU - Wang, Xinshuai

PY - 2023

Y1 - 2023

KW - PD-L1 inhibitor

KW - Triple-negative breast cancer (TNBC)

KW - anlotinib

KW - apoptosis

KW - treatment

KW - PD-L1 inhibitor

KW - Triple-negative breast cancer (TNBC)

KW - anlotinib

KW - apoptosis

KW - treatment

UR - http://hdl.handle.net/10807/260221

U2 - 10.21037/atm-22-6446

DO - 10.21037/atm-22-6446

M3 - Article

SN - 2305-5839

VL - 11

SP - 83

EP - 83

JO - Annals of Translational Medicine

JF - Annals of Translational Medicine

ER -